Edition:
United Kingdom

Rohto Pharmaceutical Co Ltd (4527.T)

4527.T on Tokyo Stock Exchange

2,580JPY
16 Aug 2019
Change (% chg)

¥-6 (-0.23%)
Prev Close
¥2,586
Open
¥2,564
Day's High
¥2,592
Day's Low
¥2,557
Volume
268,800
Avg. Vol
328,840
52-wk High
¥4,155
52-wk Low
¥2,546

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2019 Mar '19 48,887.00 -9.406
Dec 47,436.00 31.067
Sep 46,621.00 33.892
Jun 40,638.00 30.071
FY 2018 Mar '18 47,633.00 -7.137
Dec 45,611.00 38.943
Sep 42,661.00 29.476
Jun 35,837.00 19.887
FY 2017 Mar '17 43,177.00 13.962
Dec 40,124.00 36.933
Sep 38,419.00 24.654
Jun 32,879.00 12.017
 
*Note: Units in Millions ofYen
**Note: Units in Yen

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Dec-19 1 48,600.00 48,600.00 48,600.00 --
Quarter Ending Mar-19 1 48,665.00 48,665.00 48,665.00 --
Year Ending Mar-19 4 183,465.00 184,000.00 182,500.00 --
Year Ending Mar-20 5 186,520.00 188,700.00 184,000.00 187,517.00
Year Ending Mar-21 5 192,280.00 196,000.00 188,600.00 196,420.00
Earnings (per share)
Quarter Ending Mar-19 1 21.50 21.50 21.50 --
Year Ending Mar-19 4 114.23 118.00 109.70 --
Year Ending Mar-20 5 118.25 122.80 104.40 125.19
Year Ending Mar-21 5 127.02 134.20 112.30 137.35
Sales and Profit Figures in Japanese Yen (JPY);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) 37.43 29.73 33.85
P/E High - Last 5 Yrs. 36.64 47.56 54.29
P/E Low - Last 5 Yrs. 22.55 27.30 28.22
Beta 0.78 1.00 0.99
Price to Sales (TTM) 2.06 6.00 7.90
Price to Book (MRQ) 2.78 3.84 4.38
Price to Tangible Book (MRQ) 2.96 4.14 5.07
Price to Cash Flow (TTM) 23.31 21.62 23.70
% Owned Institutions -- 0.79 1.78

Dividends

  Company industry sector
Dividend Yield 0.72 1.83 1.67
Dividend Yield - 5 Year Avg 0.90 1.47 1.37
Dividend 5 Year Growth Rate 5.02 6.74 6.82
Payout Ratio(TTM) 29.06 50.64 46.67

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago 2.63 13.42 14.65
Sales (TTM) vs TTM 1 Yr. Ago 6.89 6.45 8.45
Sales - 5 Yr. Growth Rate 5.00 8.32 9.43
EPS (MRQ) vs Qtr. 1 Yr. Ago -31.80 18.49 19.40
EPS (TTM) vs TTM 1 Yr. Ago 5.49 -- --
EPS - 5 Yr. Growth Rate 2.20 5.66 7.15
Capital Spending - 5 Yr. Growth Rate 0.61 7.02 8.01

Financial Strength

  Company industry sector
Quick Ratio (MRQ) 1.42 2.52 2.52
Current Ratio (MRQ) 1.92 3.55 3.52
LT Debt to Equity (MRQ) 1.13 11.64 12.61
Total Debt to Equity (MRQ) 6.22 16.17 17.64
Interest Coverage (TTM) 56.47 7.61 14.93

Profitability Ratios

  Company industry sector
Gross Margin (TTM) 59.66 51.41 50.25
Gross Margin - 5 Yr. Avg. 59.37 50.53 51.36
EBITD Margin (TTM) 14.82 -- --
EBITD - 5 Yr. Avg 13.96 17.64 16.42
Operating Margin (TTM) 9.88 -2.19 -6.97
Operating Margin - 5 Yr. Avg. 9.05 13.94 11.87
Pre-Tax Margin (TTM) 8.88 -2.50 -7.30
Pre-Tax Margin - 5 Yr. Avg. 9.16 18.73 15.72
Net Profit Margin (TTM) 5.35 -6.21 -11.11
Net Profit Margin - 5 Yr. Avg. 5.66 14.06 11.11
Effective Tax Rate (TTM) 39.76 20.27 20.61
Effective Tax Rate - 5 Yr. Avg. 38.25 22.92 24.51

Efficiency

  Company industry sector
Revenue/Employee (TTM) 28,887,800 1,012,949,194 870,638,159
Net Income/Employee (TTM) 1,545,083 118,477,208 101,855,832
Receivable Turnover (TTM) 3.89 5.61 5.88
Inventory Turnover (TTM) 2.62 2.59 3.66
Asset Turnover (TTM) 0.92 0.88 0.85

Management Effectiveness

  Company industry sector
Return on Assets (TTM) 4.92 10.57 10.25
Return on Assets - 5 Yr. Avg. 5.11 11.70 11.17
Return on Investment (TTM) 7.13 13.04 12.69
Return on Investment - 5 Yr. Avg. 7.50 14.80 14.15
Return on Equity (TTM) 7.57 14.12 17.13
Return on Equity - 5 Yr. Avg. 8.06 15.92 15.53
  1 Year 3 Year 5 Year
Sales % 6.89 3.20 5.00
EPS (TTM) % 5.49 2.43 2.20
Dividend % 4.55 4.77 5.02
Note: Units in Millions of US Dollars

Performance for Rohto Pharmaceutical Co Ltd

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week 8.58 7.18 99 47
13 Week 1.93 4.94 99 34
26 Week 9.90 9.52 99 15
52 Week -6.48 5.08 99 66
YTD 5.83 0.62 99 20
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 40.66%
# of Holders: 120
Total Shares Held: 47,972,054
3 Mo. Net Change: 1,709,098
# New Positions: 2
# Closed Positions: 2
# Increased Positions: 29
# Reduced Positions: 16
# Net Buyers: 13
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.